Newsroom

Categories: Biotechnology, Clinical Research & Trials

Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours

December 3, 2024

Categories: Omics & Genetics, Clinical Research & Trials

Azenta obtains regulatory approval for clinical long-read Whole Genome Sequencing test

November 14, 2024

Categories: Computing & Technology, Clinical Research & Trials

MMS named a finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

November 8, 2024

Categories: Computing & Technology, Clinical Research & Trials

CRDSA announces publication of Standards for Clinical Trial Data Reuse

September 26, 2024

Categories: Biotechnology, Clinical Research & Trials

Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial

September 24, 2024

Categories: COVID-19, Clinical Research & Trials

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

September 18, 2024

Categories: Healthcare, Clinical Research & Trials

Two new scoping reviews of heated tobacco science by Imperial Brands further substantiate the category's tobacco harm reduction potential

August 12, 2024

Categories: Healthcare, Clinical Research & Trials

Trial approval for new pacemaker aiming to boost recovery in heart failure

July 23, 2024

Categories: General Laboratory, Clinical Research & Trials, Corporate, Finance & Investor

‘Biolyst Scientific’ announced as new brand name to encompass EMS and Azer, will deepen offerings to clinical and research lab customers

July 22, 2024